Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Neo Health (OTC) Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (252)
Cancellation by sponsor (56)
Cancellation or suspension (2)
Prescription medicine registration (1)

Date

2025 (31)
2024 (64)
2023 (59)
2022 (25)
2021 (41)
2020 (28)
2019 (12)
2018 (13)
2017 (21)
2016 (10)
2015 (2)
2014 (1)
2010 (1)
1991 (3)

Search

Sponsor content

311 result(s) found, displaying 281 to 290

FAMCICLOVIR NHPL famciclovir 125 mg tablet blister pack (266473)

24 February 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for FAMCICLOVIR NHPL famciclovir 125 mg tablet blister pack.
FAMCICLOVIR NHPL famciclovir 500 mg tablet blister pack (266475)

24 February 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for FAMCICLOVIR NHPL famciclovir 500 mg tablet blister pack.
FAMCICLOVIR NHPL famciclovir 250 mg tablet blister pack (266474)

24 February 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for FAMCICLOVIR NHPL famciclovir 250 mg tablet blister pack.
PRICELINE PHARMACY CETIRIZINE cetirizine hydrochloride 10 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

14 October 2019

Cancellation by sponsor

Requested by Neo Health (OTC) Pty Ltd
PHARMACY HEALTH CETIRIZINE cetirizine hydrochloride 10 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

14 October 2019

Cancellation by sponsor

Requested by Neo Health (OTC) Pty Ltd
PHARMACY HEALTH MOMETASONE ALLERGY RELIEF mometasone furoate (as monohydrate) 50 mcg/ actuation suspension nasal spray bottle (285063)

30 January 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PHARMACY HEALTH MOMETASONE ALLERGY RELIEF mometasone furoate (as monohydrate) 50 mcg/ actuation suspension nasal spray bottle.
NEO HEALTH APPLE BLACKCURRANT EFFERVESCENT ELECTROLYTE TABLETS (285020)

27 January 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for NEO HEALTH APPLE BLACKCURRANT EFFERVESCENT ELECTROLYTE TABLETS.
MaxPharma Clinicals MAXCAL Cancelled under Section 30(1)(c) of the Act

12 September 2019

Cancellation by sponsor

Requested by Neo Health (OTC) Pty Ltd
Maxpharma Clinicals MAGMAX Cancelled under Section 30(1)(c) of the Act

5 September 2019

Cancellation by sponsor

Requested by Neo Health (OTC) Pty Ltd
Neo Ferrous Fumarate (283261)

6 December 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Neo Ferrous Fumarate.

Pages

First page
Previous page
…
Page 24
Page 25
Page 26
Page 27
Page 28
Current page 29
Page 30
Page 31
Page 32
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.